Apixio has raised a $13.5 million series C round of venture capital from Bain Capital Ventures and several angel investors. The company’s technology extracts data from numerous types of medical records, including patient charts and doctors’ notes, in order to help hospitals and insurance companies get a better sense of patients’ health for risk-assessment purposes. Apixio has raised more than $22 million since launching in 2009. It first launched publicly in 2011, then focusing on its semantic-analysis engine for identifying latent connections between diagnoses and symptoms.
A team of Stanford researchers has developed a method for mining the text of doctors’ notes to identify adverse reactions from prescription drugs. The technique could spot problems years before the current FDA-reporting process can.